Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Olde Rikkert

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Journal of Alzheimer'S Disease : JAD|September 4, 2014
Development of an international schedule for the assessment and staging of care for dementiaMaya Semrau, Alistair Burns, Slavica Djukic-Dejanovic, et al.
European Review of Aging and Physical Activity : Official Journal of the European Group for Research Into Elderly and Physical Activity|May 11, 2019
Is every-day walking in older adults more analogous to dual-task walking or to usual walking? Elucidating the gaps between gait performance in the lab and during 24/7 monitoringInbar Hillel, Eran Gazit, Alice Nieuwboer, et al.
Lancet (London, England)|August 16, 2016
Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trialAnat Mirelman, Lynn Rochester, Inbal Maidan, et al.
The Lancet. Neurology|June 16, 2009
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort studyPieter Jelle Visser, Frans Verhey, Dirk L Knol, et al.
Bosnian Journal of Basic Medical Sciences|September 6, 2021
Call for emergency action to limit global temperature increases, restore biodiversity, and protect healthLukoye Atwoli, Abdullah H Baqui, Thomas Benfield, et al.
Journal of Alzheimer'S Disease : JAD|October 8, 2016
The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic PatientsWillemijn J Jansen, Ron L H Handels, Pieter Jelle Visser, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-βWhitney M Freeze, Heidi I L Jacobs, Ed H Gronenschild, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2017
Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort StudyBabette L R Reijs, Stephanie J B Vos, Hilkka Soininen, et al.
BMJ Open|October 11, 2014
NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's diseaseBrian Lawlor, Sean Kennelly, Sarah O'Dwyer, et al.
Alzheimer'S Research & Therapy|June 22, 2018
Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive declineIsabelle Bos, Frans R Verhey, Inez H G B Ramakers, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Journal of Alzheimer'S Disease : JAD|September 4, 2014
Development of an international schedule for the assessment and staging of care for dementiaMaya Semrau, Alistair Burns, Slavica Djukic-Dejanovic, et al.
European Review of Aging and Physical Activity : Official Journal of the European Group for Research Into Elderly and Physical Activity|May 11, 2019
Is every-day walking in older adults more analogous to dual-task walking or to usual walking? Elucidating the gaps between gait performance in the lab and during 24/7 monitoringInbar Hillel, Eran Gazit, Alice Nieuwboer, et al.
Lancet (London, England)|August 16, 2016
Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trialAnat Mirelman, Lynn Rochester, Inbal Maidan, et al.
The Lancet. Neurology|June 16, 2009
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort studyPieter Jelle Visser, Frans Verhey, Dirk L Knol, et al.
Bosnian Journal of Basic Medical Sciences|September 6, 2021
Call for emergency action to limit global temperature increases, restore biodiversity, and protect healthLukoye Atwoli, Abdullah H Baqui, Thomas Benfield, et al.
Journal of Alzheimer'S Disease : JAD|October 8, 2016
The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic PatientsWillemijn J Jansen, Ron L H Handels, Pieter Jelle Visser, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-βWhitney M Freeze, Heidi I L Jacobs, Ed H Gronenschild, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2017
Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort StudyBabette L R Reijs, Stephanie J B Vos, Hilkka Soininen, et al.
BMJ Open|October 11, 2014
NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's diseaseBrian Lawlor, Sean Kennelly, Sarah O'Dwyer, et al.
Alzheimer'S Research & Therapy|June 22, 2018
Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive declineIsabelle Bos, Frans R Verhey, Inez H G B Ramakers, et al.
Pageof 10